Neil is a globally recognised leader in government and regulatory affairs with vast experience in patient safety, traceability/Serialisation, anti-counterfeiting, and supply chain. With a foundation in politics and financial management, strategic delivery and operational modernisation. Over the past 20 years he has led work from hospital trust level to UN and EU/FDA level. Key successes include delivering GS1 standards into over 300 NHS care settings, delivering GSK's Serialisation programme "Fingerprint", influencing at the house of Lords and speaking at the UN.

CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines. We license and distribute a portfolio of medicines for CNS, critical care and other conditions, both directly and through strategic partnerships, in over 60 countries worldwide. A certified B Corp company, our vision is to become a recognised partner of choice through our commercial excellence, patient focus and presence across Europe.